2018
Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis
Publication
Publication
Additional Metadata | |
---|---|
, , | |
doi.org/10.1136/annrheumdis-2018-213767, hdl.handle.net/1765/110205 | |
Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases | |
Organisation | Rheumatology |
Teitsma, X.M. (Xavier M.), Jacobs, J. W. G., de Jong, P., Hazes, M., Weel, A., Welsing, P., … Lafeber, F. (2018). Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis. Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases. doi:10.1136/annrheumdis-2018-213767 |